FAS and systemic lupus erythematosus: Bijl et al (8) and Caricchio et al (12) studied 13 and 25 SLE patients with similar drug dose as our study, respectively, and reported that the percentage of apoptotic cells and the expression level of Fas molecule was the same in SLE patients and healthy controls, which was comparable to our results.